| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T91 |
0-218 |
Sentence |
denotes |
The 14 serological assays listed in Table 1 were performed on each of the 23 sera from PCR confirmed COVID-19 positive patients and the 19 pre-pandemic/cross-reactive sera, according to the manufacturer’s instructions. |
| T92 |
219-277 |
Sentence |
denotes |
Sensitivity and specificity were calculated for each test. |
| T93 |
278-495 |
Sentence |
denotes |
We calculated both the overall sensitivity (day 2–18 after symptom onset) and the sensitivity of the two subgroups (day 2–7 and day 8–18), each time for IgM/A and IgG separately and for combined IgM/A and IgG testing. |
| T94 |
496-504 |
Sentence |
denotes |
Table 1. |
| T95 |
505-536 |
Sentence |
denotes |
Overview of the included assays |
| T96 |
537-594 |
Sentence |
denotes |
Test Assay Company Antibody detection Recombinant antigen |
| T97 |
595-613 |
Sentence |
denotes |
Point-of-care test |
| T98 |
614-703 |
Sentence |
denotes |
Corona Virus (COVID-19) Combined IgM/IgG Rapid Test Sol Scientifics IgM+IgG Not specified |
| T99 |
704-806 |
Sentence |
denotes |
COVID-19 IgG/igM Rapid Test Cassette Zhejiang ORIENT GENE Biotech IgM+IgG Spike + nucleocapsid protein |
| T100 |
807-917 |
Sentence |
denotes |
Wantai SARS-COV-2 Ab Rapid Test Beijing Wantai Biological Pharmacy Enterprise IgM+IgG (combined) Not specified |
| T101 |
918-986 |
Sentence |
denotes |
COVID-19 IgG/IgM RAPID TEST PRIMA PROFESSIONAL IgM+IgG Not specified |
| T102 |
987-1070 |
Sentence |
denotes |
Diagnostic Kit for IgG/IgM Antibody to SARS-CoV-2 WIZ BIOTECH IgM+IgG Not specified |
| T103 |
1071-1112 |
Sentence |
denotes |
Enzyme-Linked Immunosorbent Assay (ELISA) |
| T104 |
1113-1183 |
Sentence |
denotes |
Anti-SARS-CoV-2 ELISA (IgA) EUROIMMUN S1 Spike glycoprotein (S1domain) |
| T105 |
1184-1255 |
Sentence |
denotes |
Anti-SARS-CoV-2 ELISA (IgG) EUROIMMUN IgG Spike glycoprotein (S1domain) |
| T106 |
1256-1340 |
Sentence |
denotes |
Novel Coronavirus COVID-19 IgM ELISA Kit Epitope Diagnostics (EDI) IgM Not specified |
| T107 |
1341-1432 |
Sentence |
denotes |
Novel Coronavirus COVID-19 IgG ELISA Kit Epitope Diagnostics (EDI) IgG Nucleocapsid protein |
| T108 |
1433-1496 |
Sentence |
denotes |
SARS-CoV-2 IgM ELISA Kit Creative Diagnostics IgM Not specified |
| T109 |
1497-1560 |
Sentence |
denotes |
SARS-CoV-2 IgG ELISA kit Creative Diagnostics IgG Not specified |
| T110 |
1561-1637 |
Sentence |
denotes |
Human Anti-2019 nCoV(N) IgG ELISA kit Finetest, Wuhan Fine Biotech Co., Ltd. |
| T111 |
1638-1671 |
Sentence |
denotes |
IgG Spike glycoprotein (S1domain) |
| T112 |
1672-1721 |
Sentence |
denotes |
Chemiluminescent microparticle immunoassay (CMIA) |
| T113 |
1722-1768 |
Sentence |
denotes |
SARS-CoV-2 IgG Abbott IgG Nucleocapsid protein |
| T114 |
1769-1805 |
Sentence |
denotes |
Chemiluminescence immunoassay (CLIA) |
| T115 |
1806-1865 |
Sentence |
denotes |
Liaison SARS-CoV-2 S1/S2 IgG DiaSorin IgG S1 and S2 protein |
